Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)

BACKGROUND: Locally advanced oral squamous cell carcinoma (LAOSCC) is associated with a high rate of recurrence and poor survival. Given the recent successes of neoadjuvant immunochemotherapy (NAICT) in solid tumors, it is promising to use this treatment modality to achieve a better pathological res...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yingying, Sun, Jingjing, Li, Jun, Zhu, Dongwang, Dong, Minjun, Dou, Shengjin, Tang, Yong, Shi, Wentao, Sun, Qi, Zhao, Tongchao, Zhou, Zhihang, Zhou, Xinyu, Liu, Ying, Li, Jiang, Zhu, Guopei, Zhang, Ding, Chen, Yanan, Zhu, Qi, Ju, Wutong, Zhong, Laiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442116/
https://www.ncbi.nlm.nih.gov/pubmed/37288582
http://dx.doi.org/10.1097/JS9.0000000000000489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442116/
https://www.ncbi.nlm.nih.gov/pubmed/37288582
http://dx.doi.org/10.1097/JS9.0000000000000489

Ejemplares similares